BIOMAT Database Logo BIOMAT Database Logo

Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. 1980

E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert

UI MeSH Term Description Entries
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.
April 1990, Biophysical chemistry,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Evidence of a covalent linkage in the adriamycin-cardiolipin complex induced by adriamycin-mediated electron transport.
October 1983, Research communications in chemical pathology and pharmacology,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Adriamycin Cardiotoxicity: possible pathogenic mechanisms.
April 1981, Journal of molecular and cellular cardiology,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
A possible mechanism for adriamycin induced cardiotoxicity.
February 1994, Indian journal of experimental biology,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
July 1978, Cancer treatment reports,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
[Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat].
January 1985, Giornale italiano di chemioterapia,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Does catalase play a role in adriamycin induced cardiotoxicity?
May 1980, Pharmacological research communications,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Does catalase play a role in Adriamycin induced cardiotoxicity?
February 1981, Pharmacological research communications,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress.
October 1981, Life sciences,
E Goormaghtigh, and P Chatelain, and J Caspers, and J M Ruysschaert
A possible mechanism of adriamycin cardiotoxicity. Inhibition of NADP-linked isocitrate dehydrogenase.
January 1983, Advances in myocardiology,
Copied contents to your clipboard!